Form 8-K - Current report:
SEC Accession No. 0001493152-26-029079
Filing Date
2026-06-17
Accepted
2026-06-17 16:05:19
Documents
12
Period of Report
2026-06-11
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 8-K form8-k.htm   iXBRL 8-K 48114
  Complete submission text file 0001493152-26-029079.txt   259114

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE bfri-20260611.xsd EX-101.SCH 3765
3 XBRL DEFINITION FILE bfri-20260611_def.xml EX-101.DEF 26599
4 XBRL LABEL FILE bfri-20260611_lab.xml EX-101.LAB 36623
5 XBRL PRESENTATION FILE bfri-20260611_pre.xml EX-101.PRE 25223
15 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 5312
Mailing Address 120 PRESIDENTIAL WAY, SUITE 330 WOBURN MA 01801
Business Address 120 PRESIDENTIAL WAY, SUITE 330 WOBURN MA 01801 781-245-1325
Biofrontera Inc. (Filer) CIK: 0001858685 (see all company filings)

EIN.: 473765675 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40943 | Film No.: 261098317
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)